drugset / Trial / NCT02390154
Roniciclib Mass Balance Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this trial is to investigate the fate of the roniciclib (study drug) in the body in a so called mass-balance study. This means to investigate how the study drug is absorbed, distributed, broken down (metabolized) and removed (excreted or eliminated) from the body.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-03
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Roniciclib | Small molecule | 2.5 mg | Oral |
| Subject | Roniciclib | Small molecule | 5 mg | Oral |